Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and Colitis

pyrroles has been researched along with Colitis in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (17.65)29.6817
2010's9 (52.94)24.3611
2020's5 (29.41)2.80

Authors

AuthorsStudies
Kim, JW; Kim, SY1
Deniz, OC; Erdamar, S; Gündoğdu, Y; Köksal, İ; Saka, D; Şişman, G1
Batist, G; Esfahani, K; Hudson, M1
Hall, LJ; Hoyles, L; Kujawska, M; McCartney, AL; McCuaig, F; Shibu, P1
Ge, G; Liu, X; Wang, Q; Xia, J; Xu, F; Xu, X; Yang, Y; Zhang, W; Zhao, S1
Fujibayashi, S; Fujiya, M; Goto, T; Kashima, S; Moriichi, K; Nomura, Y; Okumura, T; Sakatani, A; Sasajima, J; Tanaka, K; Ueno, N1
D'Haens, GR; De Jonge, WJ; De Krijger, M; De Vries, LCS; Duarte, JM; Jongejan, A; Moerland, PD; Van Hamersveld, PHP; Van Leeuwen-Hilbers, FWM; Welting, O; Wildenberg, ME1
Aharoni Golan, M; Cohen, RD; Dalal, S; El Jurdi, K; Ollech, JE; Pekow, J; Rubin, DT; Sakuraba, A; Sossenheimer, PH; Weisshof, R1
Hobbenaghi, R; Malekinejad, H; Moshtaghion, SM; Shafie-Irannejad, V; Tabatabaie, SH1
Crawford, K; Dusing, M; Frischer, JS; Knod, JL1
Kaneko, A; Kawano, M; Matsushita, S; Takagi, R1
Fukudo, S; Hasegawa, R; Ito, H; Nagura, Y; Saito-Nakaya, K1
Catlett, L; Eddy, S; Gordon, M; Healey, D; Huang, B; Rini, BI; Shannon, P; Stein, M; Stephenson, JJ; Tyler, A1
Aktunc, E; Arasli, M; Barut, F; Gun, BD; Kayhan, B1
Guan, F; Ju, J; Li, G; Liu, AB; Sun, Y; Yang, CS; Yang, Z1
Belogi, L; Bettelli, E; Mezzadri, CM; Tubaro, E1
Kanagarajan, N; Murthy, S; Nam, JH; Noah, ZA1

Reviews

1 review(s) available for pyrroles and Colitis

ArticleYear
The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment.
    International journal of molecular sciences, 2021, Oct-20, Volume: 22, Issue:21

    Topics: Adamantane; Colitis; Colitis, Ulcerative; Crohn Disease; Heterocyclic Compounds, 3-Ring; Humans; Inflammatory Bowel Diseases; Janus Kinase Inhibitors; Janus Kinases; Niacinamide; Piperidines; Pyridines; Pyrimidines; Pyrroles; Triazoles

2021

Trials

1 trial(s) available for pyrroles and Colitis

ArticleYear
Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma.
    Cancer, 2011, Feb-15, Volume: 117, Issue:4

    Topics: Acute Kidney Injury; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Colitis; Death, Sudden; Drug Administration Schedule; Female; Humans; Indoles; Kidney Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Pyrroles; Sunitinib

2011

Other Studies

15 other study(ies) available for pyrroles and Colitis

ArticleYear
Sunitinib induced colitis manifesting as invasive diarrhea in a patient with renal cell carcinoma.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022, Volume: 28, Issue:2

    Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Colitis; Diarrhea; Humans; Indoles; Kidney Neoplasms; Pyrroles; Sunitinib

2022
Tofacitinib for Refractory Immune-Related Colitis from PD-1 Therapy.
    The New England journal of medicine, 2020, 06-11, Volume: 382, Issue:24

    Topics: Colitis; Colitis, Ulcerative; Humans; Piperidines; Programmed Cell Death 1 Receptor; Pyrimidines; Pyrroles

2020
Improved molecular characterization of the
    Microbial genomics, 2021, Volume: 7, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Benzodiazepines; Colitis; Enterocolitis, Necrotizing; Feces; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella oxytoca; Multigene Family; Prevalence; Pyrroles; Whole Genome Sequencing

2021
Qing-Fei-Pai-Du decoction and wogonoside exert anti-inflammatory action through down-regulating USP14 to promote the degradation of activating transcription factor 2.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021, Volume: 35, Issue:9

    Topics: Activating Transcription Factor 2; Animals; Cell Line; Colitis; Cullin Proteins; Cytokines; Dextran Sulfate; Down-Regulation; Drugs, Chinese Herbal; Flavanones; Glucosides; Inflammation; Macrophages; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Proteasome Endopeptidase Complex; Proteolysis; Pyrroles; Pyrrolidines; Ubiquitin Thiolesterase; Ubiquitination

2021
Second-line therapy for Helicobacter pylori eradication causing antibiotic-associated hemorrhagic colitis.
    Annals of clinical microbiology and antimicrobials, 2017, Aug-14, Volume: 16, Issue:1

    Topics: Abdominal Pain; Aged; Amoxicillin; Biopsy; Colitis; Colon; Colonoscopy; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Hemorrhage; Humans; Klebsiella oxytoca; Metronidazole; Mucous Membrane; Pyrroles; Rare Diseases; Sulfonamides

2017
A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function.
    Inflammatory bowel diseases, 2019, 03-14, Volume: 25, Issue:4

    Topics: Animals; Cells, Cultured; Colitis; Dextran Sulfate; Female; Humans; Janus Kinase 1; Macrophages; Mice; Mice, Inbred C57BL; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Signal Transduction

2019
Real-World Experience with Tofacitinib in IBD at a Tertiary Center.
    Digestive diseases and sciences, 2019, Volume: 64, Issue:7

    Topics: Administration, Oral; Adult; Colitis; Colitis, Ulcerative; Drug Administration Schedule; Female; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Piperidines; Pouchitis; Pyrimidines; Pyrroles; Remission Induction; Retrospective Studies; Tertiary Care Centers; Time Factors; Treatment Outcome

2019
Comparative protective effect of hawthorn berry hydroalcoholic extract, atorvastatin, and mesalamine on experimentally induced colitis in rats.
    Journal of medicinal food, 2013, Volume: 16, Issue:7

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Atorvastatin; Colitis; Crataegus; Fruit; Heptanoic Acids; Humans; Lipid Peroxidation; Male; Mesalamine; Plant Extracts; Pyrroles; Rats; Rats, Wistar

2013
Murine colitis treated with multitargeted tyrosine kinase inhibitors.
    The Journal of surgical research, 2016, Volume: 200, Issue:2

    Topics: Animals; Axitinib; Colitis; Imidazoles; Indazoles; Indoles; Male; Mice; Mice, Inbred C57BL; Microvessels; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrroles; Sorafenib; Sunitinib; Treatment Outcome

2016
Berberine is a dopamine D1- and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses.
    Journal of neuroimmunology, 2015, Dec-15, Volume: 289

    Topics: Adaptive Immunity; Animals; Benzazepines; Berberine; Bone Marrow; Colitis; Cytokines; Dendritic Cells; Dextran Sulfate; Disease Models, Animal; Dopamine Antagonists; Immunity, Innate; Lipopolysaccharides; Lymph Nodes; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Protein Binding; Pyridines; Pyrroles; Receptors, Dopamine; Receptors, Serotonin; Time Factors

2015
Corticotropin-releasing hormone receptor 1 antagonist blocks colonic hypersensitivity induced by a combination of inflammation and repetitive colorectal distension.
    Neurogastroenterology and motility, 2008, Volume: 20, Issue:10

    Topics: Animals; Colitis; Colon; Dilatation, Pathologic; Electromyography; Humans; Inflammation; Irritable Bowel Syndrome; Male; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Trinitrobenzenesulfonic Acid

2008
The effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis.
    Immunopharmacology and immunotoxicology, 2011, Volume: 33, Issue:4

    Topics: Acute Disease; Animals; Atorvastatin; Colitis; Cytokines; Disease Models, Animal; Down-Regulation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Mice; Mice, Inbred BALB C; Pyrroles; Th1 Cells; Th2 Cells

2011
Deleterious effects of high concentrations of (-)-epigallocatechin-3-gallate and atorvastatin in mice with colon inflammation.
    Nutrition and cancer, 2012, Volume: 64, Issue:6

    Topics: Animals; Atorvastatin; Azoxymethane; Catechin; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Heptanoic Acids; Leukotriene B4; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Pyrroles; Rectum; Weight Loss

2012
Impact on the bowel of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug.
    European journal of pharmacology, 2003, Apr-25, Volume: 467, Issue:1-3

    Topics: Acetic Acid; Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colon; Dose-Response Relationship, Drug; Glycine; Guinea Pigs; Ileitis; Ileum; In Vitro Techniques; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peroxidase; Pyrroles; Rats; Rats, Wistar; Sulfasalazine; Ulcer

2003
Disease modifying effect of statins in dextran sulfate sodium model of mouse colitis.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2008, Volume: 57, Issue:1

    Topics: Animals; Apolipoprotein A-I; Atorvastatin; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, HDL; Mice; Occult Blood; Pyrroles; Simvastatin; Tumor Necrosis Factor-alpha

2008